These findings indicated that hypoxia regulated the growth of ovarian cancer cells mainly through regulation of the HIF-1α-TGFA-EGFR-ErbB2-MYC axis, which might provide a new drug target and biomarker and lead to improved insights on diagnosis and treatment of ovarian cancer. The gene discussed is ERBB2; the disease is ovarian carcinoma.